Advertisement
Australia markets open in 9 hours 54 minutes
  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     
  • AUD/USD

    0.6436
    -0.0001 (-0.02%)
     
  • ASX 200

    7,642.10
    +36.50 (+0.48%)
     
  • OIL

    83.00
    +0.31 (+0.37%)
     
  • GOLD

    2,396.30
    +7.90 (+0.33%)
     
  • Bitcoin AUD

    97,503.66
    +569.23 (+0.59%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

What Kind Of Share Price Volatility Should You Expect For ICU Medical, Inc. (NASDAQ:ICUI)?

If you're interested in ICU Medical, Inc. (NASDAQ:ICUI), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second sort is caused by the natural volatility of markets, overall. For example, certain macroeconomic events will impact (virtually) all stocks on the market.

Some stocks see their prices move in concert with the market. Others tend towards stronger, gentler or unrelated price movements. Beta is a widely used metric to measure a stock's exposure to market risk (volatility). Before we go on, it's worth noting that Warren Buffett pointed out in his 2014 letter to shareholders that 'volatility is far from synonymous with risk.' Having said that, beta can still be rather useful. The first thing to understand about beta is that the beta of the overall market is one. Any stock with a beta of greater than one is considered more volatile than the market, while those with a beta below one are either less volatile or poorly correlated with the market.

Check out our latest analysis for ICU Medical

What we can learn from ICUI's beta value

While history does not always repeat, this level of beta may indicate that the stock price will continue to be exposed to market risk, albeit not overly so. Beta is worth considering, but it's also important to consider whether ICU Medical is growing earnings and revenue. You can take a look for yourself, below.

NasdaqGS:ICUI Income Statement, February 13th 2020
NasdaqGS:ICUI Income Statement, February 13th 2020

Does ICUI's size influence the expected beta?

ICU Medical is a reasonably big company, with a market capitalisation of US$4.3b. Most companies this size are actively traded with decent volumes of shares changing hands each day. It's not overly surprising to see large companies with beta values reasonably close to the market average. After all, large companies make up a higher weighting of the index than do small companies.

What this means for you:

Since ICU Medical has a beta close to one, it will probably show a positive return when the market is moving up, based on history. If you're trying to generate better returns than the market, it would be worth thinking about other metrics such as cashflows, dividends and revenue growth might be a more useful guide to the future. This article aims to educate investors about beta values, but it's well worth looking at important company-specific fundamentals such as ICU Medical’s financial health and performance track record. I urge you to continue your research by taking a look at the following:

ADVERTISEMENT
  1. Future Outlook: What are well-informed industry analysts predicting for ICUI’s future growth? Take a look at our free research report of analyst consensus for ICUI’s outlook.

  2. Past Track Record: Has ICUI been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of ICUI's historicals for more clarity.

  3. Other Interesting Stocks: It's worth checking to see how ICUI measures up against other companies on valuation. You could start with this free list of prospective options.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.